Cook Medical today agreed to sell some reproductive health and otolaryngology product lines to Cooper Cos., the companies announced.
The purchase price was $300 million. The products in the sale represent about 2.5% of Cook Medical’s sales. Manufacturing will get transferred to Cooper Cos. over a two-year period.
The news comes about three months after the Federal Trade Commission announced that the companies had abandoned a proposed $875 million acquisition of the Cook Medical Reproductive Health business. The FTC had investigated whether the previous deal was anti-competitive.
The new deal includes select products from Cook Medical’s maternal fetal medicine portfolio — as well as gynecological surgery products, Doppler monitor technology, disposable devices, and accessories.
“This acquisition is an excellent strategic fit for CooperSurgical,” CooperSurgical President Holly Sheffield said in a news release. “We’re adding highly synergistic …